Apold J - Search Results

1

High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriers.

Maehle L, Apold J, Paulsen T, Hagen B, Løvslett K, Fiane B, Van Ghelue M, Clark N, Møller P. Maehle L, et al. Among authors: apold j. Clin Cancer Res. 2008 Nov 15;14(22):7569-73. doi: 10.1158/1078-0432.CCR-08-0112. Clin Cancer Res. 2008. PMID: 19010876

2

Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy.

Møller P, Borg A, Evans DG, Haites N, Reis MM, Vasen H, Anderson E, Steel CM, Apold J, Goudie D, Howell A, Lalloo F, Maehle L, Gregory H, Heimdal K. Møller P, et al. Among authors: apold j. Int J Cancer. 2002 Oct 20;101(6):555-9. doi: 10.1002/ijc.10641. Int J Cancer. 2002. PMID: 12237897

3

Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation status.

Moller P, Evans DG, Reis MM, Gregory H, Anderson E, Maehle L, Lalloo F, Howell A, Apold J, Clark N, Lucassen A, Steel CM. Moller P, et al. Among authors: apold j. Int J Cancer. 2007 Sep 1;121(5):1017-20. doi: 10.1002/ijc.22789. Int J Cancer. 2007. PMID: 17471561

4

Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers.

Møller P, Hagen AI, Apold J, Maehle L, Clark N, Fiane B, Løvslett K, Hovig E, Vabø A. Møller P, et al. Among authors: apold j. Eur J Cancer. 2007 Jul;43(11):1713-7. doi: 10.1016/j.ejca.2007.04.023. Epub 2007 Jun 15. Eur J Cancer. 2007. PMID: 17574839

5

No sib pair concordance for breast or ovarian cancer in BRCA1 mutation carriers.

Møller P, Maehle L, Clark N, Apold J. Møller P, et al. Among authors: apold j. Hered Cancer Clin Pract. 2007 Jun 15;5(2):67-71. doi: 10.1186/1897-4287-5-2-67. Hered Cancer Clin Pract. 2007. PMID: 19725986 Free PMC article.

6

High penetrances of BRCA1 and BRCA2 mutations confirmed in a prospective series.

Møller P, Mæhle L, Engebretsen LF, Ludvigsen T, Jonsrud C, Apold J, Vabø A, Clark N. Møller P, et al. Among authors: apold j. Hered Cancer Clin Pract. 2010 Jan 19;8(1):2. doi: 10.1186/1897-4287-8-2. Hered Cancer Clin Pract. 2010. PMID: 20180971 Free PMC article.

7

The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer.

Heimdal K, Maehle L, Apold J, Pedersen JC, Møller P. Heimdal K, et al. Among authors: apold j. Eur J Cancer. 2003 Oct;39(15):2205-13. doi: 10.1016/s0959-8049(03)00548-3. Eur J Cancer. 2003. PMID: 14522380

8

The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series.

Møller P, Borg A, Heimdal K, Apold J, Vallon-Christersson J, Hovig E, Maehle L; Norwegian Inherited Breast Cancer Group; Norwegian Inherited Ovarian Cancer Group. Møller P, et al. Among authors: apold j. Eur J Cancer. 2001 May;37(8):1027-32. doi: 10.1016/s0959-8049(01)00075-2. Eur J Cancer. 2001. PMID: 11334729

9

Immunohistochemistry identifies carriers of mismatch repair gene defects causing hereditary nonpolyposis colorectal cancer.

Stormorken AT, Bowitz-Lothe IM, Norèn T, Kure E, Aase S, Wijnen J, Apold J, Heimdal K, Møller P. Stormorken AT, et al. Among authors: apold j. J Clin Oncol. 2005 Jul 20;23(21):4705-12. doi: 10.1200/JCO.2005.05.180. J Clin Oncol. 2005. PMID: 16034045

10

[Hereditary breast cancer].

Møller P, Maehle L, Apold J. Møller P, et al. Among authors: apold j. Tidsskr Nor Laegeforen. 2005 Nov 17;125(22):3136-8. Tidsskr Nor Laegeforen. 2005. PMID: 16299574 Free article. Norwegian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters